March 29, 2021
NOT-HL-21-005 - Notice of Information: NHLBI Extensions for Career Development Award (K01, K08, K23, K25) Recipients Whose Career Trajectories Have Been Significantly Impacted by COVID-19
NOT-OD-21-052 - Reminder – Requesting Extensions for Early Career Scientists Whose Career Trajectories Have Been Significantly Impacted by COVID-19
National Heart, Lung, and Blood Institute (NHLBI)
Purpose
NIH recently released NOT-OD-21-052 which provided general guidance for early career scientists affected by COVID-19 to request no-cost extensions or funded extensions. On March 16, 2021, NHLBI published NOT-HL-21-005 which provided additional guidance for currently-funded NHLBI K01, K08, K23, and K25 recipients impacted by COVID-19 seeking funded extensions. This updated Notice is being released to instruct applicants to submit electronically via PA-20-272 instead of a direct request to the applicable Grants Management Specialist and Program Official listed in the Notice of Award. New language is highlighted below in bold/italics.
Background
NHLBI investigators have been significantly affected by the COVID-19 pandemic, and several areas of need have been identified for early career scientists, in particular K01, K08, K23, and K25 recipients. To help support NHLBI career development award recipients, NHLBI is providing an opportunity for select K award recipients to apply for a funded extension to support their career development and successful transition to research independence. Due to limited funding in FY2021, the NHLBI will not be able to provide funded extensions for all K award recipients. To maximize the limited resources, NHLBI seeks to support K award recipients in the last year of their award or in their first no-cost extension (NCE) for whom an NHLBI-supported cost extension will be most impactful toward subsequent R01 funding and a transition to independent investigation.
Eligibility and Extension Criteria
Applicants must be a currently funded NHLBI K01, K08, K23, or K25 recipient in the final year of their award or in their first NCE and have experienced a minimum of a 12-week lab closure or clinical research interruption due to COVID-19. Applicants meeting these requirements will be eligible for a 4-month extension. Clinician applicants who have experienced increased clinical duties due to COVID-19 are eligible for an additional 2-month extension, for a total combined 6-month extension. Any funded extensions will be for salary support only and not for additional resources or research expenses.
Currently funded NHLBI K01, K08, K23, or K25 recipients with an unobligated balance equivalent to 1 year or more of funding are not eligible for this extension. In addition, NHLBI K01, K08, K23, or K25 award recipients who have successfully competed as a PD/PI for a research project grant (RPG) with direct costs of ≥ $100,000 per year are not eligible for this extension.
While NHLBI Fellowship (“F”) and K99 recipients are not eligible for this extension, they may contact their Program Officer to discuss the effects of COVID-19 on their awards.
Application and Submission Information
Currently funded NHLBI K01, K08, K23, and K25 recipients impacted by COVID-19 seeking funded extensions must apply using the following opportunity announcement:
All instructions in the SF424 (R&R) Application Guide and PA-20-272 must be followed, with the following additions:
R&R Other Project Information Form (Other Attachments)
PHS 398 Career Development Award Supplemental Form:
R&R Budget Form: Provide a budget and budget justification, including an estimate of funds remaining on the award at the end of the current budget period and a description of why the remaining funds cannot be used to cover the requested extension.
Roya Kalantari, Ph.D.
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-480-1989
Email: NHLBIKExtension@nhlbi.nih.gov
Wayne Wang, Ph.D.
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0535
Email: NHLBIKExtension@nhlbi.nih.gov